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Multidrug resistance (MDR) in Salmonella enterica
serotype Typhimurium has substantial public health and
economic impact. Recent epidemiologic data highlighted
broadening of antibiotic resistance spectra in this serotype
(1), along with worldwide distribution of MDR S. Typhimurium
clones (2). These clones may have been selected by
indiscriminate use of antimicrobial agents in clinical practice
and animal husbandry. Understanding the genetic
mechanism(s) responsible for acquisition and spread of
antibiotic resistance could facilitate development of effective
prevention and control strategies.
Acquisition of mobile genetic elements encoding multiple
antibiotic resistance genes is the main mechanism for short-
term accumulation of resistance determinants in bacterial
genomes. Resistance (R-) plasmids of the IncFI incompatibil-
ity group have been associated with emergence of MDR
S. enterica serotypes (3). IncFI plasmids were found most
often in Middle Eastern isolates of S. Typhimurium, but
similar plasmids were also identified in Salmonella serotypes
from Africa, Europe, and North America (3). Convincing
epidemiologic and genetic data support the view that
acquisition of IncFI plasmids contributed in the mid-1970s to
epidemic spread of S. enterica serotype Wien. The IncFI-
carrying salmonellae were responsible for protracted
outbreaks of severe pediatric infections that were difficult to
treat because of the wide spectrum of antimicrobial resistance
(4). Most of IncFI plasmids isolated in the early 1970s from
epidemic  S. Typhimurium and S. Wien strains conferred
resistance to ampicillin (Ap), chloramphenicol (Cm),
streptomycin (Sm), spectinomycin (Sp), sulphonamides (Su),
tetracycline (Tc), mercuric ions (Hg), and occasionally
kanamicin (Km) (3). A few IncFI plasmids, particularly those
from Mediterranean S. Wien isolates, lacked R-SmSpSu
determinants (5). After the S. Wien epidemics waned in the
early 1980s, outbreaks linked to IncFI-carrying Salmonella
strains have occasionally been reported (6).
We have recently shown that 37 MDR S. Typhimurium
strains isolated from 1996 to 1997 from sporadic cases of
pediatric gastroenteritis harbored conjugative IncFI plas-
mids of around 120 kilobases (kb) with the common
profile R-ApCmKmSmSuTp (7). Conjugal transfer of a
prototypic IncFI plasmid (designated IncFI/97) from the type
strain ST366 to Escherichia coli K-12 was associated with
transmission of the entire resistance cluster. We demonstrat-
ed that most of the antibiotic-resistance genes in this plasmid
were located in integrons (7). These genetic elements encode a
site-specific recombinase (integrase) capable of capturing
resistance genes, which are assembled as gene cassettes
controlled by the strong promoter Pant. Gene cassettes are
flanked by two conserved segments, the 5'CS and 3'CS,
encoding the integrase (intI1) and the sulphonamide
resistance determinant (sul1), respectively (8).
Two integrons were identified in IncFI/97: In-t1
(R-CmKmSu), carrying the aadB and catB3 genes, and In-t2
(R-ApSmSu), carrying the oxa1 and aadA1  genes (7).
Integrons are now recognized as the main genetic vehicles of
antibiotic resistance in gram-negative bacteria (9), but it
remains unclear to what extent these elements contributed to
the expansion of the antibiotic resistance repertoire of IncFI
plasmids.
The Study
To gain insight into the evolution of the resistance
determinants on IncFI plasmids, we compared the R-profile
and the integron content of IncFI/97 with that of five IncFI
plasmids representative of those identified in epidemic
S. Typhimurium and S. Wien from human sources during
1970-1978 (Table). Prototypic plasmids were transferred to
E. coli K-12 either by conjugation (11) or conventional
electrotransformation before antibiotic-susceptibility testing
by the disc-diffusion method (12). All but one plasmid showed
a common core of antibiotic resistance (R-ApCmTcHgKm),
while additional resistance to Sm, Sp, and Su was observed in
plasmids IncFI/97, NTP101, pZM3, and TP181.
The IncFI collection was screened for the presence of the
integrase gene intI1. Six IncFI plasmids were purified from
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E. coli K-12 recipients (13), analyzed by agarose gel
electrophoresis (Figure 1A), and hybridized with a Tn21-derived
intI1 probe. The class 1 integrase gene(s) was located on IncFI
plasmids carrying the R-SmSpSu determinants, including
isolates from the 1970s as well as more recent ones
(Figure 1B). This is the first demonstration of integron
presence in MDR Salmonella isolates traced to the early 1970s.
To define the structure of integrons carried by IncFI
plasmids, Southern blot hybridization of PvuII-BamHI-
digested DNA with the intI1 probe was performed. The In-t2
integron was conserved in all the integrase-positive
plasmids,  including IncFI/97, NTP101, pZM3, and TP181
(Figure 1C). This observation indicates that In-t2 has been
maintained unaltered in IncFI plasmids for nearly 30 years.
IncFI/97 is likely to be a new plasmid variant, since it
contains a second integron, designated In-t1 (7), which
appears as a smaller band on the hybridization profile
(Figure 1C). Sequence data confirmed the structural
organization of the integrons (Figure 1D).
To further explore the structural identity between recent
and ancestral IncFI plasmids, restriction enzyme analysis of
plasmid DNAs was performed with SalI and SphI
endonucleases. Based on electrophoretic patterns (Figure 2A),
moderate similarity between IncFI/97 and IncFI plasmids
isolated in the early 1970s can be recognized. The presence of
similar-sized restriction fragments is particularly evident for
plasmids carrying the In-t2 integron, including IncFI/97,
NTP101, pZM3, and TP181. This finding suggests that the
evolution of MDR-IncFI plasmids may have occurred through
the sequential acquisition of integrons.
To investigate the potential inheritance of genetic
elements from ancestral to recent IncFI plasmids, we probed
our collection for the presence of additional resistance
determinants. Plasmid pZM3 was previously described to
contain an IS15-like composite element (IS1936-Kmr)
conferring Km-resistance (10). This structure is located
within a Tn21 derivative (Tn1935), which also carries an Ap-
resistance (oxa-1) gene upstream of the resident Sm-
resistance (aadA1) gene of Tn21, in addition to the distal Hg-
resistance determinant (10). Although the manner by which
new antibiotic resistance genes are acquired by Tn21-like
transposons was unclear at the time pZM3 was characterized
(10), acquisition of oxa-1 likely occurred by integrase-
mediated recombination. This event led to the assembly of In-
t2 from its putative precursor, the Tn21-borne In2 integron
Table. Designation and relevant characteristics of representative IncFI plasmids used for genetic analysis of integrons
No. Plasmid         Host strain  Origin, yeara          Resistance patternb Trac  kb Reference
1 IncFI/97 ST 366 Albania, 1997 Ap Cm Sm Sp Su Tc Hg Km Tp + 120   7
2 NTP101 ST DT 208 England, 1974 Ap Cm Sm Sp Su Tc Hg - 135   3
3 pZM3 SW 20 Algeria, 1970 Ap Cm Sm Sp Su Tc Hg Km + 165 10
4 TP181 ST DT 208 Iran, 1975 Ap Cm Sm Sp Su Tc Hg Km + 165   3
5 pZM111 SW WZM111 Italy, 1978 Ap Cm Hg Km Gm + 130   5
6 PZM61 SW WZM6 Italy, 1974 Ap Cm Tc Hg Km - 145 11
a Year of isolation.
b Abbreviations: Ap = ampicillin; Cm = chloramphenicol; Sm = streptomycin; Sp = spectinomycin; Su = sulfonamides; Tc = tetracycline; Hg = mercuric ions; Km
= kanamycin; Tp = trimethoprim; Gm = gentamicin.
cAutotransferring properties.
Figure 1. Structural organization of integrons carried by IncFI
plasmids. Numbers above each lane indicate plasmid reference
numbers as defined (Table). Lane C shows the plasmidless E. coli K-
12 strain CSH26 (11). A: agarose (0.8%) gel electrophoresis in 1x Tris-
borate-EDTA buffer of plasmid DNA extracted from E. coli K-12
exconjugants. DNA was stained with ethidium bromide and
visualized under UV light. B: Southern blot hybridization of plasmids
shown in panel A with the intI1 probe. C: Southern blot hybridization
with the intI1 probe of PvuII-BamHI double-digested DNA from
E. coli K-12 exconjugants. The DNA was extracted as described (7).
The intI1 probe was amplified with primers corresponding to nt 4680-
4700 and nt 5252-5232 of the released Tn21 sequence (GenEMBL
accession no. AF071413). Plasmid pACYC184::Tn21 (10) was used as
the template. The probe was labeled with [α -32P]dCTP by using a
random priming kit (GibcoBRL). Chromosomal DNA fluoresced
because of weak trapping of partially degraded plasmids.
D: schematic representation of In-t2 and In-t1 integrons. The thick
bars above each structure represent the DNA fragments recognized
by the intI1 probe. The 4.0-kb PvuII-BamHI fragment (In-t2)
encompasses the intI1 gene segment downstream of the conserved
PvuII site (0.6 kb), the oxa1 and aadA1 gene cassettes (2.2 kb), and
the 3’-CS comprising the sul1 gene upstream of the BamHI site (1.2
kb) (7,8). The 1.2-kb PvuII-BamHI fragment (In-t1) encompasses the
intI1 gene segment and part of the aadB gene cassette (7).Dispatches
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(9). Therefore, we tested IncFI plasmids for the presence of the
IS1936-Kmr element, the transposase (tnp) machinery, and
the Hg-resistance (mer) locus. All but one of the IncFI
plasmids carry the IS1936-Kmr element (Figure 2B). NTP101
is the only exception, consistent with the Km-susceptible
phenotype conferred by this plasmid. Additional bands, some
of which were shared by different IncFI plasmids, were also
detected, likely as a result of cross-hybridization of the probe
with IS15-like elements located on these replicons. Plasmids
IncFI/97, NTP101, PZM3, and TP181 were also positive for
the presence of the 4.4-kb SphI band (Figure 2C), which is
predicted to contain the tnpM (regulator), the tnpR
(resolvase), and part of the tnpA (transposase) genes of Tn21-
like transposons (GenEMBL accession no. AF071413).
Furthermore, the IncFI plasmids recognized by the merA
probe also showed a common SphI band of 2.1 kb, providing
evidence for a structural conservation of the mer operon
(Figure 2D). Plasmid pZM61 showed hybridization patterns
indistinguishable from those of pZM111 (data not shown).
Taken together, the above data indicate that IncFI/97
shares antibiotic resistance determinants with the ancestor
plasmids pZM3, NTP101, and TP181, suggesting that MDR
developed through independent acquisition of integrons
within the structurally conserved IncFI plasmid scaffold. The
evolutionary story of these plasmids combines the
maintenance of indigenous antibiotic resistance genes with
the acquisition of new determinants, leading to accumulation
of multiple resistance mechanisms. For example, the oxa1
gene cassette was acquired despite the presence of the TEM-
type beta-lactamase encoded by the preexisting TnA
transposon (11). Likewise, acquisition of In-t1 introduced a
third aminoglycoside-resistance determinant (aadB) in
addition to the resident IS1936-Kmr (aph) element (10) and
the In-t2-encoded aadA1 gene. Along the same lines,
resistance to chloramphenicol was determined by both the
catB3 gene cassette of In-t1 and by the resident cmlA gene.
Besides increasing the level of antibiotic resistance due to the
expression of multiple detoxification mechanisms, acquisi-
tion of new resistance genes is also expected to enlarge the
spectrum of resistance. Our results (not shown) indicate that
In-t2 serves as a vehicle for the oxa-1 gene, extending beta-
lactam resistance to ureidopenicillins, and of the aadA1 gene,
conferring resistance to streptomycin and spectinomycin.
Likewise, the In-t1-carried aadB gene broadens the
aminoglycoside resistance to tobramycin and gentamicin.
Conclusions
Our retrospective investigation provides novel evidence
for the involvement of integrons in the development of MDR
through sequential acquisition of new resistance determi-
nants within IncFI plasmids. This family of replicons could
play a role in the future development of resistance in
S. Typhimurium and, more generally, in Enterobacteriaceae.
A dramatic outcome of this evolutionary pathway may be
predicted from the intrinsic structural and functional
properties of mobile DNA elements found on these
R-plasmids. Integrons provide a unique mechanism for the
recruitment of additional resistance genes. Moreover,
spreading resistance genes among different replicons is
favored by the location of integrons within transposable
elements. Finally, horizontal transmission is expected
because of the conjugative or mobilizable properties of IncFI
carriers, which enables them to traverse species and genus
boundaries. Future success in controlling resistance depends,
at least in part, on a complete understanding of the
mechanisms involved in dissemination. A systematic search
Figure 2. Restriction enzyme analysis and
detection of common genetic elements in
IncFI plasmids. Numbers above each lane
indicate plasmid reference numbers as
defined (Table). M and M' are HindIII-
digested lambda DNA and 1-kb plus DNA
ladder (GibcoBRL), respectively. A: agarose
(0.8%) gel electrophoresis in 1x Tris-borate-
EDTA buffer of plasmids digested with
restriction endonucleases SalI and SphI.
DNA was stained with ethidium bromide
and visualized under UV light. B: Southern
blot hybridization of SalI-digested plas-
mids with the IS1936-Kmr probe purified as
1.8-kb  SalI fragment from plasmid
pACYC184::Tn1935 (10). C and D: South-
ern blot hybridizations of SphI-digested
plasmids with the tnpM and merA probes,
respectively. The tnpM probe was amplified
with primers corresponding to nt 3689-3709
and nt 4070-4050 of the released Tn21
sequence  (GenEMBL accession no.
AF071413). For synthesis of the merA probe,
primers annealing to nt 17224-17249 and
nt 17931-17907 of the Tn21 sequence were
used. Plasmid pACYC184::Tn21 (10) was
used as the template. Probes were labeled
with [α -32P]dCTP by using a random
priming kit (GibcoBRL, Rockville, MD).
The arrows point to predicted hybridization
fragments.Dispatches
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for integrons and transposable elements could provide a
useful genetic basis for MDR in human and animal
S. Typhimurium isolates.
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